About Bure Equity AB 
Bure Equity AB
Finance
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Company Coordinates 
Company Details
Nybrogatan 6 , STOCKHOLM None : 114 34
Registrar Details
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
Mr. Patrik Tigerschiold
Chairman of the Board
Mr. Carl Bjorkman
Independent Director
Mr. Carsten Browall
Independent Director
Mr. Bengt Engstrom
Independent Director
Ms. Charlotta Falvin
Independent Director
Ms. Sarah McPhee
Independent Director
Revenue and Profits:
Net Sales:
193 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1,250 Million
Finance
SEK 18,641 Million (Small Cap)
3.00
NA
1.09%
-999,999.00
28.13%
0.91






